Advanced Filters
noise

A, Kuopio N Clinical Trials

A listing of A, Kuopio N clinical trials actively recruiting patients volunteers.

Found 11,558 clinical trials
D David Briskey, PhD

A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA

This is a randomised, double-blind, parallel, placebo-controlled study in healthy subjects to compare the absorption of two microalgal formulations, to a fish oil and a placebo.

18 - 64 years of age All Phase 4
D Doctor

Efficacy of a New Infant Formula Composition on Gut Health in Infants

The aim of this study is to investigate potential health benefits of the experimental formula. The main objective is whether the experimental formula elevates the relative abundance of Bifidobacterium in stool samples after 10 weeks, as compared a standard formula, aka control formula. In addition other markers of gut health, …

- 3 years of age All Phase N/A
E Esther Janssen, PhD

Optimizing Recovery After Reverse Shoulder Arthroplasty With a Personalized Mobile Health Application

Background: Mobile health (mHealth) - the use of medical applications in healthcare settings - include tools that can support self-management after surgery and thereby contribute to early postoperative recovery. Providing patients with timely and interactive information through mHealth is hypothesized to positively influence recovery after reverse shoulder arthroplasty (RSA). Aim: …

18 years of age All Phase N/A
W Wenliang Li

A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor

This study includes phase I dose escalation part and phase IIa dose expansion part. The goal of this clinical trial is to learn if C5252 treatment is safe and well tolerated in patients with intracranial tumor and to learn preliminary efficacy of C5252. In this study, participants will be given …

18 years of age All Phase 1/2
A Alistair Mallard

A Study Testing the Safety and Effects of FB102 in Healthy Volunteers

The purpose of this Phase 1 trial is to evaluate the safety and effects of FB-102 in healthy volunteers following single and multiple doses.

18 - 60 years of age All Phase 1

A Phase I Study of CS5007 in Participants With Advanced Solid Tumors

This is a first-in-human (FIH), open-label, and multi-center Phase I study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of CS5007 as monotherapy in participants with advanced solid tumors. The study is comprised of a Phase Ia dose escalation and Phase Ib dose expansion.

18 years of age All Phase 1
B Benoît LE GOFF, Dr

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Pigmented villonodular synovitis (PVNS) is a rare joint disease caused by the proliferation of synovial tissue, leading to significant pain and joint destruction. It typically begins between the ages of 30 and 50 and significantly affects patients' functionality. The proliferation is due to somatic mutations in some fibroblastic cells within …

18 years of age All Phase N/A
E Esraa Eid, MSc

Peroxide Versus Non-Peroxide In-Office Tooth Bleaching: A Randomized Clinical Trial

This randomized clinical trial aims to compare the effectiveness of peroxide and non-peroxide in-office tooth bleaching systems. The study will evaluate tooth whitening efficacy, color durability over time, and tooth sensitivity after treatment. Participants will receive one of the two bleaching treatments and will be followed for six months to …

18 - 45 years of age All Phase N/A
M Michela Deiana, Dr.

Development of a Duodenal Organoid Model for Host-Intestinal Pathogen Interaction Studies

The goal of this clinical trial is to develop an in vitro model based on human duodenal organoids for the study of interactions between the human intestinal epithelium and enteric pathogens. Patients subjected to surgical removal of a portion of the duodenum for clinical indications, with availability of histologically normal …

18 years of age All Phase N/A
P Peng Liu, Ph.D

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

The purpose of this study is to evaluate how well IBI3003 works when compared with the investigator's choice regimen (DPd or PVd or SVd)

18 years of age All Phase 3

Simplify language using AI